MedTrace Logo

Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer

NCT06342284 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2026-04-13

No results posted yet for this study

Summary

This is an observational study involving the collection of patient-generated health data using an Apple Watch, a home pulse oximeter, and a smartphone during a course of proton beam radiotherapy for lung cancer. The study period over which this information is collected will range from the day of study enrollment until two weeks after radiotherapy completion. Subjects will complete a short satisfaction survey at the end of the study period. Other information that is collected as part of routine care for this patient population will be extracted from subjects' medical records during the study period and afterwards.

Conditions

  • Thoracic Cancer

Interventions

RADIATION

Proton Beam Radiation with or without concurrent chemotherapy

Curative-intent fractionated proton beam thoracic radiotherapy, with or without concurrent chemotherapy

Sponsors & Collaborators

  • The New York Proton Center

    lead OTHER

Principal Investigators

  • Nitin Ohri, MD · Montefiore Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-22
Primary Completion
2028-03-31
Completion
2031-03-21

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06342284 on ClinicalTrials.gov